Rosen Law Firm says Hims investors can seek lead plaintiff role in securities case
Rosen Law Firm says it filed a securities class action over Hims & Hers Health stock purchases from Aug. 4, 2025, to July 29, 2026.
Rosen Law Firm says it filed a securities class action over Hims & Hers Health stock purchases from Aug. 4, 2025, to July 29, 2026.
Rosen Law Firm said on Sept. 2, 2026, that a securities class action has been filed against Hims & Hers Health, Inc. on behalf of purchasers of its securities during the stated class period. The notice says investors who want to serve as lead plaintiff must move the court by Nov. 2, 2026.
In the notice, Rosen says the company shared consumers' health information with third-party advertising platforms, charged for prescriptions almost immediately after intake forms were submitted, and suggested consumers could consult a medical provider to find the right treatment. The notice also says those practices exposed Hims to regulatory scrutiny and possible fees and penalties.
The notice was issued as a law-firm publicity release rather than as an independent court summary. It does not include a case caption, docket number, judge or venue. It also does not provide an official company response. According to the notice, the claims cover the period from Aug. 4, 2025, through July 29, 2026, inclusive.
Rosen said the lawsuit alleges that positive statements about Hims' business, operations and prospects lacked a reasonable basis or were materially misleading. The notice says investors suffered damages when the true details entered the market. It also says potential claimants may be able to seek compensation through a contingency fee arrangement, meaning no out-of-pocket fees or costs if they join through the firm.
The notice directs investors seeking more information to the Rosen Law Firm join page and lists a phone number and email contact. It identifies Rosen as a global investor rights law firm and says the notice was datelined New York.
The notice gives no additional filing details and does not say whether Hims has responded publicly to the allegations. The lead-plaintiff deadline is Nov. 2, 2026.
Sources
Editorial note: This article was prepared with AI assistance and includes source attribution for reader review.
View the Web StoryA visual, tap-through version of this reportThis is the AMP version of the article. Read the full article on Atlas Watchline.